Search research articles
Contact Us
Filters
Showing results (131-140 of 165) with videos related to
Page
of 17
Sort By:
Journal of Medical Genetics
|
September 22, 2001
Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis
R Clementi, U zur Stadt, G Savoldi, et al.
Immunology Letters
|
January 1, 1996
Ontogeny of CD40L [corrected] expression by activated peripheral blood lymphocytes in humans
D Brugnoni, P Airò, D Graf, et al.
British Journal of Haematology
|
September 30, 1998
Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatment
F Bozzi, G Lefranc, A Villa, et al.
Immunobiology
|
September 19, 2000
Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model
L D Notarangelo, S Giliani, P Mella, et al.
Prenatal Diagnosis
|
March 12, 1999
Prenatal molecular diagnosis of Wiskott-Aldrich syndrome by direct mutation analysis
S Giliani, M Fiorini, P Mella, et al.
Bone Marrow Transplantation
|
April 30, 2002
B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency
J Bartolomé, F Porta, A Lafranchi, et al.
Clinical Immunology (Orlando, Fla.)
|
May 4, 2000
Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterization
P Mella, L Imberti, D Brugnoni, et al.
Immunology Today
|
October 1, 1995
BTKbase: a database of XLA-causing mutations. International Study Group
M Vihinen, M D Cooper, G de Saint Basile, et al.
Molecular and Cellular Biology
|
July 13, 2000
Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D)J recombination and result in primary immunodeficiencies
C A Gomez, L M Ptaszek, A Villa, et al.
The Journal of Experimental Medicine
|
August 10, 2000
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells
S Parolini, C Bottino, M Falco, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 165) with videos related to
Sort By:
Page
of 17
Journal of Medical Genetics
|
September 22, 2001
Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis
R Clementi, U zur Stadt, G Savoldi, et al.
Immunology Letters
|
January 1, 1996
Ontogeny of CD40L [corrected] expression by activated peripheral blood lymphocytes in humans
D Brugnoni, P Airò, D Graf, et al.
British Journal of Haematology
|
September 30, 1998
Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatment
F Bozzi, G Lefranc, A Villa, et al.
Immunobiology
|
September 19, 2000
Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model
L D Notarangelo, S Giliani, P Mella, et al.
Prenatal Diagnosis
|
March 12, 1999
Prenatal molecular diagnosis of Wiskott-Aldrich syndrome by direct mutation analysis
S Giliani, M Fiorini, P Mella, et al.
Bone Marrow Transplantation
|
April 30, 2002
B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency
J Bartolomé, F Porta, A Lafranchi, et al.
Clinical Immunology (Orlando, Fla.)
|
May 4, 2000
Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterization
P Mella, L Imberti, D Brugnoni, et al.
Immunology Today
|
October 1, 1995
BTKbase: a database of XLA-causing mutations. International Study Group
M Vihinen, M D Cooper, G de Saint Basile, et al.
Molecular and Cellular Biology
|
July 13, 2000
Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D)J recombination and result in primary immunodeficiencies
C A Gomez, L M Ptaszek, A Villa, et al.
The Journal of Experimental Medicine
|
August 10, 2000
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells
S Parolini, C Bottino, M Falco, et al.
Page
of 17